Rethinking the secondary prevention of superficial bladder cancer: is there a role for retinoids?
- 1 September 2000
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 85 (9) , 1023-1026
- https://doi.org/10.1046/j.1464-410x.2000.00655.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997
- A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder CancerJournal of Urology, 1996
- The safety of etretinate as long-term therapy for psoriasis: Results of the Etretinate Follow-up StudyJournal of the American Academy of Dermatology, 1995
- Retinoids and Cancer: A Basis for Differentiation TherapyCancer Investigation, 1993
- Chemoprevention of exprimental bladder cancerJournal of Cellular Biochemistry, 1992
- Evaluation of the actions and interactions of retinoic acid and epidermal growth factor on transformed urothelial cells in culture: Implications for the use of retinoid therapy in the treatment of bladder cancer patientsClinical Oncology, 1992
- Effects of Carotenoid Administration on Bladder Cancer PreventionOncology, 1991
- Can dietary beta-carotene materially reduce human cancer rates?Nature, 1981
- 13- cis -Retinoic Acid: Inhibition of Bladder Carcinogenesis in the RatScience, 1977
- TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMINThe Journal of Experimental Medicine, 1925